Milo Frattini

11.9k total citations · 3 hit papers
109 papers, 7.6k citations indexed

About

Milo Frattini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Milo Frattini has authored 109 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 34 papers in Pathology and Forensic Medicine. Recurrent topics in Milo Frattini's work include Colorectal Cancer Treatments and Studies (39 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (21 papers). Milo Frattini is often cited by papers focused on Colorectal Cancer Treatments and Studies (39 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (21 papers). Milo Frattini collaborates with scholars based in Italy, Switzerland and United States. Milo Frattini's co-authors include Francesca Molinari, Luca Mazzucchelli, Piercarlo Saletti, Alberto Bardelli, Federica Di Nicolantonio, Sara De Dosso, Andrea Sartore‐Bianchi, Salvatore Siena, Miriam Martini and Sabrina Arena and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Milo Frattini

105 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

2008 1.3k citations Federica Di Nicolantonio, Miriam Martini et al. profile →
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

2009 601 citations Andrea Sartore‐Bianchi, Miriam Martini et al. Cancer Research profile →
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

2010 573 citations Wendy De Roock, Federica Di Nicolantonio et al. profile →

Peers

Countries citing papers authored by Milo Frattini

Since Specialization

Citations

This map shows the geographic impact of Milo Frattini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milo Frattini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milo Frattini more than expected).

Fields of papers citing papers by Milo Frattini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milo Frattini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milo Frattini. The network helps show where Milo Frattini may publish in the future.

Co-authorship network of co-authors of Milo Frattini

This figure shows the co-authorship network connecting the top 25 collaborators of Milo Frattini. A scholar is included among the top collaborators of Milo Frattini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milo Frattini. Milo Frattini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lung Cancers Associated with Cystic Airspaces 2025 ·Cancers ·(unknown), Francesco Petrella, (unknown), Milo Frattini, (unknown), (unknown), Giorgio Treglia, Stefania Rizzo	0
2	Neo-RAS Wild Type or RAS Conversion in Metastatic Colorectal Cancer: A Comprehensive Narrative Review 2024 ·Cancers ·(unknown), (unknown), (unknown), Elena Trevisi, Sara De Dosso, Milo Frattini	3
3	Identification of MGMT Downregulation Induced by miRNA in Glioblastoma and Possible Effect on Temozolomide Sensitivity 2023 ·Journal of Clinical Medicine ·Andrea Cardia, (unknown), Ismail Zaed, Nora Sahnane, Roberta Cerutti, (unknown), (unknown), Paolo Spina, Federico Mattia Stefanini, Michele Cerati, Sergio Balbi, Luca Mazzucchelli, Fausto Sessa, Gianfranco Pesce, Michael Reinert, Milo Frattini, Francesco Marchi	4
4	Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors 2021 ·Clinical Cancer Research ·Ilaria Colombo, Sofia Genta, Federica Martorana, Monia Guidi, Milo Frattini, Eleftherios Pierre Samartzis, Simone Brandt, (unknown), (unknown), Mariarosa Pascale, Tatiana Terrot, Cristiana Sessa, Anastasios Stathis	27
5	A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies 2021 ·PLoS ONE ·Steffen Grann Jensen, (unknown), (unknown), (unknown), Alice Riva, Alessia Paganotti, (unknown), Rasmus K. Petersen, Michael Børgesen, Francesca Molinari, Renzo Boldorini, Jan Lorenzen, Erik Sørensen, Ulf Bech Christensen, Estrid Høgdall, Milo Frattini	6
6	Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial 2018 ·Oral Oncology ·Marco Siano, Vittoria Espeli, Nicolas Mach, Paolo Bossi, Lisa Licitra, Michele Ghielmini, Milo Frattini, Silvana Canevari, Loris De Cecco	10
7	SensiScreen® KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations 2017 ·PLoS ONE ·Alice Riva, Michael Børgesen, (unknown), (unknown), (unknown), Christina Andersen, (unknown), (unknown), (unknown), Stephen Hamilton‐Dutoit, Jan Lorenzen, Ulf Bech Christensen, Milo Frattini	6
8	Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases 2016 ·Endocrine Pathology ·Massimo Bongiovanni, Silvia Uccella, Luca Giovanella, Francesca Molinari, Milo Frattini, Gianlorenzo Dionigi, Eliana Piantanida, (unknown), Fausto Sessa, Stefano La Rosa	0
9	BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. 2014 ·PubMed ·Francesca Molinari, Stefano Signoroni, Andrea Lampis, Cláudia Bertan, Federica Perrone, Paola Sala, P Mondini, Stefano Crippa, Lucio Bertario, Milo Frattini	6
10	Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis 2013 ·Cancer Research ·Miriam Martini, Mariangela Russo, Simona Lamba, Elisa Vitiello, Emily Crowley, Francesco Sassi, Davide Romanelli, Milo Frattini, Antonio Marchetti, Alberto Bardelli	16
11	ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy 2013 ·Cancer Chemotherapy and Pharmacology ·Sara De Dosso, (unknown), (unknown), Renzo Boldorini, Angelica Sonzogni, R. Biffi, Nicola Fazio, Eugênio Bucci, (unknown), Stefano Crippa, Piercarlo Saletti, Milo Frattini	36
12	KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors 2012 ·Clinical Cancer Research ·Claudia Miranda, (unknown), Francesca Molinari, Elena Conca, Maria Chiara Anania, Andrea Bordoni, Piercarlo Saletti, Luca Mazzucchelli, Silvana Pilotti, Marco A. Pierotti, Elena Tamborini, Angela Greco, Milo Frattini	145
13	Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features. 2012 ·PubMed ·V. Martin, Francesca Botta, (unknown), Francesca Molinari, Stefania Crippa, Luca Mazzucchelli, Milo Frattini	53
14	Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study 2011 ·Journal of Clinical Pathology ·Andrea Sartore‐Bianchi, Steffen Fieuws, Silvio Veronese, Mauro Moroni, Nicola Personeni, Milo Frattini, Valter Torri, Federico Cappuzzo, Sara Vander Borght, Vittoria Martin, Margaret C. Skokan, Armando Santoro, Marcello Gambacorta, Sabine Tejpar, Marileila Varella‐Garcia, Salvatore Siena	30
15	PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies breakdown → 2009 ·Cancer Research ·Andrea Sartore‐Bianchi, Miriam Martini, Francesca Molinari, Silvio Veronese, Michele Nichelatti, Salvatore Artale, Federica Di Nicolantonio, Piercarlo Saletti, Sara De Dosso, Luca Mazzucchelli, Milo Frattini, Salvatore Siena, Alberto Bardelli	601
16	Role of Kras mutations in predicting response and survival in irinotecan-refiractory patients treated with cetuximab and irinotecan for metastatic colorectal cancer: Analysis of 281 patients with individual data 2008 ·Annals of Oncology ·Francesco Fiore, Eric Van Cutsem, Pierre Laurent‐Puig, Nicola Personeni, Salvatore Siena, Milo Frattini, Wendy De Roock, Astrid Lièvre, Andrea Sartore‐Bianchi, (unknown), Sabine Tejpar	5
17	Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005. 2008 ·PubMed ·Paola Mazzola, Alessandra Spitale, (unknown), Luca Mazzucchelli, Milo Frattini, Andrea Bordoni	29
18	Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis 2007 ·Clinical Cancer Research ·Stefano Signoroni, Milo Frattini, Tiziana Negri, Elisa Pastore, Elena Tamborini, Paola Casieri, Marta Orsenigo, Luca Riva, Paolo Radice, Paola Sala, Alessandro Gronchi, Lucio Bertario, Marco A. Pierotti, Silvana Pilotti	72
19	Neuroendocrine Small Cell Carcinoma of the Cervix Associated with Endocervical Adenocarcinoma 2007 ·Acta Cytologica ·(unknown), Gian Paolo Dagrada, Milo Frattini, Federica Perrone, Silvana Pilotti	19
20	Reconstitution of Human Telomerase Reverse Transcriptase Expression Rescues Colorectal Carcinoma Cells from In vitro Senescence: Evidence against Immortality as a Constitutive Trait of Tumor Cells 2005 ·Cancer Research ·Piero Dalerba, Cristiana Guiducci, Pietro Luigi Poliani, Ingrid Cifola, Mariella Parenza, Milo Frattini, Gianfrancesco Gallino, Ileana Carnevali, (unknown), Salvatore Andreola, Claudia Lombardo, Licia Rivoltini, Tamás Schweighoffer, Filiberto Belli, Mario P. Colombo, Giorgio Parmiani, Chiara Castelli	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact